Christine Fox, EVP, Head of U.S. Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 30,000 shares at $25.11 ($753K) on 2025-11-14, disclosed to the SEC on 2025-11-18.
Open-market sale of $753k TEVA by EVP, Head of U.S. Commercial. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TEVA | SELL | 2026-03-06 | $591K | — | Filing → |
| TEVA | SELL | 2025-11-24 | $1.4M | — | Filing → |
| TEVA | SELL | 2025-03-06 | $161K | — | Filing → |